The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Open accessAbstract
Abstract —C-reactive protein, a hepatic acute phase protein largely regulated by circulating levels of interleukin-6, predicts coronary heart disease incidence in healthy subjects. We have shown that subcutaneous adipose tissue secretes interleukin-6 in vivo. In this study we have sought associations of levels of C-reactive protein and interleukin-6 with measures of obesity and of chronic infection as their putative determinants. We have also related levels of C-reactive protein and interleukin-6 to markers of the insulin resistance syndrome and of endothelial dysfunction. We performed a cross-sectional study in 107 nondiabetic subjects: (1) Levels of C-reactive protein, and concentrations of the proinflammatory cytokines interleukin-6 and tumor necrosis factor-α, were related to all measures of obesity, but titers of antibodies to Helicobacter pylori were only weakly and those of Chlamydia pneumoniae and cytomegalovirus were not significantly correlated with levels of these molecules. Levels of C-reactive protein were significantly related to those of interleukin-6 ( r =0.37, P <0.0005) and tumor necrosis factor-α ( r =0.46, P <0.0001). (2) Concentrations of C-reactive protein were related to insulin resistance as calculated from the homoeostasis model assessment model, blood pressure, HDL, and triglyceride, and to markers of endothelial dysfunction (plasma levels of von Willebrand factor, tissue plasminogen activator, and cellular fibronectin). A mean standard deviation score of levels of acute phase markers correlated closely with a similar score of insulin resistance syndrome variables ( r =0.59, P <0.00005), this relationship being weakened only marginally by removing measures of obesity from the insulin resistance score ( r =0.53, P <0.00005). These data suggest that adipose tissue is an important determinant of a low level, chronic inflammatory state as reflected by levels of interleukin-6, tumor necrosis factor-α, and C-reactive protein, and that infection with H pylori , C pneumoniae , and cytomegalovirus is not. Moreover, our data support the concept that such a low-level, chronic inflammatory state may induce insulin resistance and endothelial dysfunction and thus link the latter phenomena with obesity and cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is confirmed by studies that describe a close interrelation of slightly elevated serum levels of C-reactive protein (IL-6-dependent) and a key element of the energy re-allocation program, namely insulin resistance [9,10].”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Self-citationVan Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Thompson, S. G., Kienast, J., Pyke, S., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,819
Flagged first, then by citations
Research works printed but not linked: 12
- 1988, Lab Invest, 58, 249
- 10.1161/circ.94.5.874 · DOI
- 1997, J Clin Endocrinol Metab, 82, 4196
- 1995, J Clin Endocrinol, 9, 61
- 10.1161/circ.94.5.922 · DOI
- 10.1161/atvb.15.9.1330 · DOI
- 10.1161/atvb.16.3.450 · DOI
- 1989, J Lab Clin Med, 113, 586
- 10.1161/atvb.17.10.2167 · DOI
- 1982, Proc Natl Acad Sci U S A, 82, 912
- 1992, Cancer Res, 52, 4113
- 10.1161/atvb.15.1.52 · DOI
Cited by
Sorted by citations
Items 701–800 of 1,003
Abdi, H., Zhao, B., Darbandi, M., Ghayour‐Mobarhan, M., Tavallaie, S., Rahsepar, A. A., Parizadeh, S. M. R., Safariyan, M., Nemati, M., Mohammadi, M., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/603539 · Cited by 76
Obesity and stroke: Can we translate from rodents to patients?
Haley, M., & Lawrence, C. B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16670411 · Cited by 79
Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology
Yudkin, J. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0711-3 · Cited by 75
Self-citationGonzález, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06579 · Cited by 76
The insulin resistance syndrome: implications for thrombosis and cardiovascular disease
Juhan-Vague, I., Morange, P., & Alessi, M. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073579 · Cited by 75
Piéroni, L., Bastard, J., Piton, A., Khalil, L., Hainque, B., & Jardel, C. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70019-8 · Cited by 75
Plutzky, J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00614-3 · Cited by 75
Donges, C. E., Duffield, R., Guelfi, K. J., Smith, G. C., Adams, D. R., & Edge, J. A. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0443 · Cited by 74
Vandercappellen, E. J., Koster, A., Savelberg, H. H. C. M., Eussen, S. J. P. M., Dagnelie, P. C., Schaper, N. C., Schram, M. T., Kallen, C., van Greevenbroek, M. M. J., Wesselius, A., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05651-3 · Cited by 76
Self-citationObesity and Low-Grade Inflammation among Young Finnish Men with Early-Onset Alopecia
Hirsso, P., Rajala, U., Hiltunen, L. A., Jokelainen, J. J., Keinanen-Kiukaanniemi, S. M., & Näyhä, S. (2007) · Dermatology · doi:10.1159/000098570 · Cited by 74
LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-α in human adipocytes
Hoch, M., Eberlé, A. N., Peterli, R., Peters, T. T. A., Seboek, D., Keller, U. B., Müller-Stich, B. P., & Linscheid, P. (2007) · Cytokine · doi:10.1016/j.cyto.2007.10.008 · Cited by 74
Direct comparison of dietary portfolio vs statin on C-reactive protein
Jenkins, D. J. A., Kendall, C. W. C., Marchie, A., Faulkner, D. A., Josse, A. R., Wong, J. M., de Souza, R. J., Emam, A., Parker, T. L., Li, T. J., et al. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602152 · Cited by 74
Role of C Reactive Protein (CRP) in Leptin Resistance
Hribal, M. L., Fiorentino, T. V., & Sesti, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990016 · Cited by 75
Mráček, T., Gao, D., Tzanavari, T., Bao, Y., Xiao, X., Stocker, C. J., Trayhurn, P., & Bing, C. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0299 · Cited by 74
Guerrero‐Romero, F., & Rodríguez‐Morán, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801954 · Cited by 74
Association between C-reactive protein and hypertension in healthy middle-aged men and women
Bautista, L. E., Atwood, J. E., Pg, O., & Taylor, A. J. (2004) · Coronary Artery Disease · doi:10.1097/00019501-200409000-00006 · Cited by 74
Choi, K. M., Lee, J., Lee, K. W., Seo, J. A., Oh, J.-H., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.10.007 · Cited by 74
CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects
Holdstock, C., Lind, L., Engstrom, B. E., Ohrvall, M., Sundbom, M., Larsson, A., & Karlsson, F. A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803000 · Cited by 73
Adipose Tissue Interleukin‐18 mRNA and Plasma Interleukin‐18: Effect of Obesity and Exercise
Leick, L., Lindegaard, B., Stensvold, D., Plomgaard, P., Saltin, B., & Pilegaard, H. (2007) · Obesity · doi:10.1038/oby.2007.528 · Cited by 73
Choi, H.-A., Cho, D. H., Shin, H., & Park, J. B. (2004) · Circulation Journal · doi:10.1253/circj.68.297 · Cited by 73
Mechanisms of Adiponectin-Associated Perivascular Function in Vascular Disease
Withers, S., Bussey, C. E., Saxton, S. N., Melrose, H. M., Watkins, A., & Heagerty, A. M. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303031 · Cited by 73
Olsson, M. M., Olsson, B., Jacobson, P., Thelle, D. S., Björkegren, J., Walley, A. J., Froguel, P., Carlsson, L. M. S., & Sjöholm, K. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.011 · Cited by 72
Association of inflammation with worsening HOMA-insulin resistance
Park, K., Steffes, M., Lee, D.-H., Himes, J. H., & Jacobs, D. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1486-5 · Cited by 72
Ladwig, K., Marten‐Mittag, B., Löwel, H., Döring, A., & Köenig, W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi456 · Cited by 72
Fcγ Receptors and Ligands and Cardiovascular Disease
Tanigaki, K., Sundgren, N. C., Khera, A., Vongpatanasin, W., Mineo, C., & Shaul, P. W. (2015) · Circulation Research · doi:10.1161/circresaha.116.302795 · Cited by 73
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy
Putz, D., Goldner, W. S., Bar, R. S., Haynes, W. G., & Sivitz, W. I. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.013 · Cited by 72
Neutrophil Activation and C‐Reactive Protein Concentration in Preeclampsia
Belo, L., Santos‐Silva, A., CASLAKE, M. J., Cooney, J., Pereira‐Leite, L., Quintanilha, A. T., & Rebelo, I. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120021059 · Cited by 72
Adiponectin: a key fat-derived molecule regulating inflammation
Tilg, H., & Wolf, A. M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.245 · Cited by 71
Physiological role of adiponectin in different tissues: a review
Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 73
Obesity and Brain Function: The Brain–Body Crosstalk
Sui, S. X., & Pasco, J. A. (2020) · Medicina · doi:10.3390/medicina56100499 · Cited by 74
The relationship of inflammatory cytokines with asthma and obesity
Canãz, M., Erdenen, F., Uzun, H., MÜDERRİSOĞLU, C., & Aydın, S. (2008) · Clinical and investigative medicine · doi:10.25011/cim.v31i6.4924 · Cited by 72
Papadakis, J. A., Sidiropoulos, P. I., Karvounaris, S. A., Vrentzos, G. E., Spanakis, E. K., Ganotakis, E. S., Kritikos, H. D., Mikhailidis, D. P., & Boumpas, D. (2009) · PubMed · Cited by 71
Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice
Um, J., Rim, H.-K., Kim, S., Kim, H., & Hong, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029524 · Cited by 71
Type 2 diabetes mellitus as inflammatory disease
Zozulińska‐Ziółkiewicz, D., & Wierusz‐Wysocka, B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.007 · Cited by 70
Deficiency in Interferon-γ Results in Reduced Body Weight and Better Glucose Tolerance in Mice
Wong, N., Fam, B. C., Cempako, G. R., Steinberg, G. R., Walder, K. R., Kay, T. W. H., Proietto, J., & Andrikopoulos, S. (2011) · Endocrinology · doi:10.1210/en.2011-0288 · Cited by 70
Sung, K., Rhee, E., Ryu, S., & Beck, S. H. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.040 · Cited by 71
Pancreastatin-Dependent Inflammatory Signaling Mediates Obesity-Induced Insulin Resistance
Bandyopadhyay, G. K., Lu, M. L., Avolio, E., Siddiqui, J. A., Gayen, J. R., Wollam, J., Vu, C. U., Chi, N., O’Connor, D. T., & Mahata, S. K. (2014) · Diabetes · doi:10.2337/db13-1747 · Cited by 71
Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study
Oruç, N., Özütemız, Ö., Yüce, G., Akarca, U. S., Ersöz, G., Günşar, F., & Batur, Y. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-16 · Cited by 72
Otake, H., Shite, J., Shinke, T., Watanabe, S., Tanino, Y., Ogasawara, D., Sawada, T., Hirata, K., & Yokoyama, M. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.07.041 · Cited by 71
Acute effects of periodontal therapy on bio‐markers of vascular health
D’Aiuto, F., Parkar, M. H., & Tonetti, M. S. (2007) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2006.01037.x · Cited by 71
Heald, A. H., Anderson, S. G., Ivison, F., Laing, I., Gibson, M., & Cruickshank, K. J. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00235-1 · Cited by 71
Volp, A. C. P., Alfenas, R. D. C. G., Costa, N. M. B., Minim, V. P. R., Stringheta, P. C., & Bressan, J. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000300015 · Cited by 70
Bertran, N., Camps, J., Fernandez-Ballart, J. D., Arija, V., Ferré, N., Tous, M., Simo, D., Murphy, M. M., Vilella, E., & Joven, J. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.11.002 · Cited by 68
Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese
Cheung, B. M. Y., Ong, K. L., Cheung, R. V., Wong, L. Y. F., Wat, N. M. S., Tam, S., Leung, G. M., Cheng, C. H., Woo, J., Janus, E. D., et al. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.111 · Cited by 70
Ayça, B., Akın, F., Çelik, Ö., Şahin, İ., Yildiz, S. S., Avcı, İ. İ., Gülşen, K., Okuyan, E., & Dinçkal, M. H. (2014) · Angiology · doi:10.1177/0003319714542997 · Cited by 70
Wunder, D. M., Yared, M. A., Bersinger, N. A., Widmer, D., Kretschmer, R., & Birkhäuser, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02178 · Cited by 71
Low‐grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia
Pirro, M., Schillaci, G., Savarese, G., Gemelli, F., Vaudo, G., Siepi, D., Bagaglia, F., & Mannarino, E. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01345.x · Cited by 70
Vijay, S. K., Mishra, M., Kumar, H., & Tripathi, K. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0054-7 · Cited by 69
Ünek, İ. T., Bayraktar, F., Solmaz, D., Ellıdokuz, H., Şişman, A. R., Yuksel, F., & Yeşil, S. (2010) · Clinical Medicine & Research · doi:10.3121/cmr.2010.889 · Cited by 69
Sun, X., Feng, R., Li, Y., Lin, S., Zhang, W., Li, Y., Sun, C., & Li, S. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001056 · Cited by 70
Chen, J., Zhao, J., Huang, J., Su, S., Qiang, B., & Gu, D. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0585-5 · Cited by 69
Yang, Y. C., Li, T., & Ji, Y. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1210 · Cited by 68
Teixeira‐Lemos, E., Reis, F., Baptista, S., Pinto, R. M. A., Sepodes, B. M. N., Vala, H., Rocha‐Pereira, P., Santos‐Silva, A., & Teixeira, F. J. (2007) · PubMed · Cited by 68
Kim, K., Valentine, R. J., Shin, Y.-J., & Gong, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.009 · Cited by 68
The Metabolic Syndrome: Definitions, Prevalence and Management
Levesque, J., & Lamarche, B. (2008) · Lifestyle Genomics · doi:10.1159/000112457 · Cited by 71
van Bussel, B. C. T., Henry, R. M. A., Schalkwijk, C. G., Ferreira, I., Feskens, E. J. M., Streppel, M. T., Smulders, Y. M., Twisk, J. W. R., & Stehouwer, C. D. A. (2011) · Journal of Nutrition · doi:10.3945/jn.111.139733 · Cited by 67
Self-citationHegele, R. A., Kraw, M. E., Ban, M. R., Miskie, B. A., Huff, M. W., & Cao, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000047460.27435.b8 · Cited by 68
Lundman, P., Eriksson, M. J., Silveira, A. M. V., Hansson, L., Pernow, J., Ericsson, C.-G. Ö., Hamsten, A., & Tornvall, P. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00165-6 · Cited by 68
Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods
McConnell, J. P., Branum, E. L., Ballman, K. V., Lagerstedt, S. A., Katzmann, J. A., & Jaffe, A. S. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.011 · Cited by 68
Cellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 68
Nakanishi, N., SHIRAISHI, T., & Wada, M. (2005) · Circulation Journal · doi:10.1253/circj.69.386 · Cited by 68
Endothelial Dysfunction in Obesity and Therapeutic Targets
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_17 · Cited by 78
Matsumoto, K., Sera, Y., Abe, Y., Ueki, Y., Tominaga, T., & Miyake, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00198-9 · Cited by 67
Vinagre, I., Sánchez‐Quesada, J. L., Sánchez-Hernández, J. J., Santos, D., Ordóñez‐Llanos, J., de Leiva, A., & Pérez, A. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-34 · Cited by 67
Adipose expression of adipocytokines in women with polycystic ovary syndrome
Svendsen, P. F., Christiansen, M., Hedley, P. L., Nilas, L., Pedersen, S. B., & Madsbad, S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.056 · Cited by 67
Cytokines and Chemokines as Biomarkers of Community-Acquired Bacterial Infection
Holub, M., Lawrence, D. A., Andersen, N. J., Davidová, A., Beran, O., Marešová, V., & Chalupa, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/190145 · Cited by 67
Zimmermann, M. B., & Herter‐Aeberli, I. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.202 · Cited by 67
Foroughi, M., Maghsoudi, Z., Khayyatzadeh, S. S., Ghiasvand, R., Askari, G., & Iraj, B. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.176368 · Cited by 70
The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment
Xu, Y., Zhou, H., & Zhu, Q. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00106 · Cited by 67
Kaplan, R. C., & Frishman, W. H. (2001) · Heart Disease · doi:10.1097/00132580-200109000-00009 · Cited by 67
Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men
Khairy, P., Rinfret, S., Tardif, J., Marchand, R., Shapiro, S., Brophy, J. M., & Dupuis, J. (2003) · Circulation · doi:10.1161/01.cir.0000064895.89033.97 · Cited by 67
Lipaemia, Inflammation and Atherosclerosis
van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 67
Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal Disease
McFarlane, S. I., & Sowers, J. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021443 · Cited by 67
Cardiovascular Risks Associated With Obesity in Children and Adolescents
Ho, T. F. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n1p48 · Cited by 65
Heliövaara, M. K., Teppo, A. M., Karonen, S. ‐., Tuominen, J. A., & Ebeling, P. R. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00463.x · Cited by 65
Overactive bladder: Is there a link to the metabolic syndrome in men?
Kirby, M. G., Wagg, A., Cardozo, L., Chapple, C. R., Castro-Diaz, D. M., Ridder, D. J. M. K. D., Espuña‐Pons, M., Haab, F., Kelleher, C. J., KÖLBL, H., et al. (2010) · Neurourology and Urodynamics · doi:10.1002/nau.20892 · Cited by 66
The Effect of Weight Loss on a Stable Biomarker of Inflammation, C-Reactive Protein
Dietrich, M., & Jialal, I. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00107.x · Cited by 66
Ajjan, R., & Grant, P. J. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.023 · Cited by 64
Gadéa, É., Thivat, É., Planchat, E., Morio, B., & Durando, X. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00957.x · Cited by 70
Anan, F., Takahashi, N., Nakagawa, M., Ooie, T., Saikawa, T., & Yoshimatsu, H. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.012 · Cited by 65
Lihn, A. S., Pedersen, S. B., Lund, S. A., & Richelsen, B. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.004 · Cited by 65
Changes in inflammatory biomarkers after successful lifestyle intervention in obese children.
Garanty‐Bogacka, B., Syrenicz, M., Goral, J., Krupa, B., Syrenicz, J., Walczak, M., & Syrenicz, A. (2011) · PubMed · Cited by 65
Whitaker, K. M., Marino, R. C., Haapala, J. L., Foster, L., Smith, K. D., Teague, A. M., Jacobs, D. R., Fontaine, P. L., McGovern, P. M., Schoenfuss, T. C., et al. (2017) · Obesity · doi:10.1002/oby.22025 · Cited by 65
Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment
Jakubowska, J., Bohdanowicz-Pawlak, A., Milewicz, A., Szymczak, J., Bednarek-Tupikowska, G., & Demissie, M. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802128968 · Cited by 65
Zymosan-induced inflammation stimulates neo-adipogenesis
Thomas, G. P. L., Hemmrich, K., Abberton, K. M., McCombe, D., Penington, A., Thompson, E. W., & Morrison, W. A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803702 · Cited by 65
Endothelial dysfunction in endocrine disease
Abdu, T. A. M. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00425-8 · Cited by 64
PPARs and the orchestration of metabolic fuel selection
Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64
The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD?
Diamant, M., & Tushuizen, M. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0061-4 · Cited by 64
Male pattern baldness and its association with coronary heart disease: a meta-analysis
Yamada, T., Hara, K., Umematsu, H., & Kadowaki, T. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002537 · Cited by 64
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers
Angoff, R., Mosarla, R. C., & Tsao, C. W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709396 · Cited by 64
Goralski, K. B., & Sinal, C. J. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-092 · Cited by 66
Houben, A. J. H. M., Eringa, E. C., Jonk, A. M., Serné, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0214-0 · Cited by 62
Self-citationCalabrò, P., Cirillo, P. L., Limongelli, G., Maddaloni, V., Riegler, L., Palmieri, R., Pacileo, G., Rosa, S. D., Pacileo, M., Palma, R. D., et al. (2010) · Journal of Vascular Research · doi:10.1159/000318775 · Cited by 64
Gomaraschi, M., Basilico, N., Sisto, F., Taramelli, D., Eligini, S., Colli, S., Sirtori, C. R., Franceschini, G., & Calabresi, L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.003 · Cited by 64
The role of lipoproteins and inflammation in cognitive decline: Do they interact?
van den Kommer, T. N., Dik, M. G., Comijs, H. C., Jonker, C., & Deeg, D. J. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.024 · Cited by 64
Güldiken, S., Demir, M., Arıkan, E., Turgut, B., Azcan, Ş., Gerenli, M., & Tuğrul, A. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.12.019 · Cited by 64
Deans, K. A., Bezlyak, V., Ford, I., Batty, G. D., BURNS, H. J. G., Cavanagh, J., de Groot, E., McGinty, A., Millar, K., Shiels, P. G., et al. (2009) · BMJ · doi:10.1136/bmj.b4170 · Cited by 64
The metabolic syndrome and the risk of arterial and venous thrombosis
Franchini, M., Targher, G., Montagnana, M., & Lippi, G. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.09.010 · Cited by 64
C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease
Lowe, G. D. O., Sweetnam, P. M., YARNELL, J. W. G., Rumley, A., Rumley, C. N., Bainton, D., & Ben‐Shlomo, Y. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000141842.27810.a9 · Cited by 64
Exposure to the Saturated Free Fatty Acid Palmitate Alters BV-2 Microglia Inflammatory Response
Tracy, L. M., Bergqvist, F., Ivanova, E. V., Jacobsen, K. T., & Iverfeldt, K. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0068-7 · Cited by 63
Metadata
- Authors
- Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W.
- Affiliations
- Whittington Hospital (GB)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-04
- Volume
- 19
- Issue
- 4
- Pages
- 972-978
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2119316150
- Cited by
- 2,465
- References
- 51
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 21 · 2023: 45 · 2022: 50 · 2021: 61 · 2020: 44 · 2019: 57 · 2018: 57 · 2017: 67 · 2016: 80 · 2015: 100 · 2014: 111 · 2013: 116 · 2012: 117
- FWCI
- 54.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- TNO Repository (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Wellcome Trust
- British Heart Foundation
- Diabetes Fonds
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- C-reactive protein, interleukin-6, TNF-α, obesity, insulin resistance, endothelial dysfunction, adipose tissue, chronic inflammation, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus, acute phase proteins, cardiovascular risk
- MeSH terms
- Adipose Tissue, Adult, Aged, C-Reactive Protein, Endothelium, Vascular, Female, Follow-Up Studies, United Kingdom, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Random Allocation, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review